Rosa-Bjorkeson Dagmar
CIK 0001643934
Director
Filings
7
Latest Oct 1, 2024
Issuers covered
2
Showing
7 of 7
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -6.5% | -6.5% | -6.5% | -6.5% |
| 90 days | 1 | 0% | -22.5% | -22.5% | -22.5% | -22.5% |
| 180 days | 1 | 100% | +45.4% | +45.4% | +45.4% | +45.4% |
| 365 days | 1 | 100% | +43.0% | +43.0% | +43.0% | +43.0% |
Issuers
Companies where Rosa-Bjorkeson Dagmar has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XNCR | Xencor Inc | 4 | Oct 1, 2024 |
| ICPT | Intercept Pharmaceuticals, Inc. | 3 | Nov 13, 2023 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|